Difference between revisions of "Talk:Assessment of the health impacts of H1N1 vaccination/Group D"
Line 38: | Line 38: | ||
{{defend|J3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}} | {{defend|J3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}} | ||
− | :{{defend|D7 |Although the causal relationship between the Pandemrix vaccine and increased narcolepsy cases is not yet confirmed, THL stoped the vaccinations as a safety measure | + | :{{defend|D7 |Although the causal relationship between the Pandemrix vaccine and increased narcolepsy cases is not yet confirmed, THL stoped the vaccinations as a safety measure until the matter can be fully investigated. A potential link between the Pandemrix vaccine and narcolepsy will be investigated in Finland by paedriatic neurologists and THL experts.|--[[User:Minna Ruokolainen|Minna Ruokolainen]] 21:51, 3 April 2011 (EEST)}} [http://www.thl.fi/en_US/web/en/pressrelease?id=22930] |
− | :{{attack|D8 |The most of the narcolepsy cases in Finland are observed among the children. THL should not have used Pandemrix at all or at least for the vaccination of children, because the WHO recommendations for not using the Pandemrix-vaccine for chilred were available before THL launched the vaccination campaing. |--[[User:Minna Ruokolainen|Minna Ruokolainen]] 21:33, 3 April 2011 (EEST)}} [http://www.rokotusinfo.fi/rokotteet/sikainfluenssa_html] | + | :{{attack|D8 |The most of the narcolepsy cases in Finland are observed among the children. THL´s decision is far too late and THL should not have used Pandemrix at all or at least for the vaccination of children, because the WHO recommendations for not using the Pandemrix-vaccine for chilred were available before THL launched the vaccination campaing. |--[[User:Minna Ruokolainen|Minna Ruokolainen]] 21:33, 3 April 2011 (EEST)}} [http://www.rokotusinfo.fi/rokotteet/sikainfluenssa_html] |
}} | }} | ||
Revision as of 18:54, 3 April 2011
Pandemrix should not be used because of narcolepsy risk
- Group members: Carmen, Minna & June
Statements:
Resolution:
(A stable resolution, when found, should be updated to the main page.) |
Argumentation:
⇤D5 : Compared to other vaccines, Pandemrix has a lower Hg content (2.5 vs 25 µg), which could cause neurological problems in children --Carmen Gil 11:25, 1 April 2011 (EEST),[1] ⇤D3b : The vaccine may still have been used where no other option was available and upon consideration in individual cases, for instance for people travelling to areas where an epidemic was in progress. --Carmen Gil 11:25, 1 April 2011 (EEST),[2] ⇤J1 Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST)
←D3a : The decision to use Pandemrix was probably led by panic and other choices should be considered at this point when narcolepsy cases were identified. --Carmen Gil 11:25, 1 April 2011 (EEST)
←J2 The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)
←J3 : In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [8]
|
--# : General comment: Add links to the pages from where you found the arguments. See Group E. --Jouni 07:45, 2 April 2011 (EEST)
--# : JUNE: I have your notebook. --Jouni 11:50, 1 April 2011 (EEST)